Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability - Archive ouverte HAL Access content directly
Journal Articles Drug Delivery Year : 2021

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability

(1) , (1) , (1) , (2) , (3) , (3) , (3) , (3) , (4) , (5) , , (6) , (6) , (3) , (1)
1
2
3
4
5
6

Abstract

Poor aqueous solubility of eplerenone (EPL) is a major obstacle to achieve sufficient bioavailability after oral administration. In this study, we aimed to develop and evaluate eplerenone nanocrystals (EPL-NCs) for solubility and dissolution enhancement. D-optimal combined mixture process using Design-Expert software was employed to generate different combinations for optimization. EPL-NCs were prepared by a bottom-up, controlled crystallization technique during freeze-drying. The optimized EPL-NCs were evaluated for their size, morphology, thermal behavior, crystalline structure, saturation solubility, dissolution profile, in vivo pharmacokinetics, and acute toxicity. The optimized EPL-NCs showed mean particle size of 46.8 nm. Scanning electron microscopy revealed the formation of elongated parallelepiped shaped NCs. DSC and PXRD analysis confirmed the crystalline structure and the absence of any polymorphic transition in EPL-NCs. Furthermore, EPL-NCs demonstrated a 17-fold prompt increase in the saturation solubility of EPL (8.96 vs. 155.85 µg/mL). The dissolution rate was also significantly higher as indicated by ∼95% dissolution from EPL-NCs in 10 min compared to only 29% from EPL powder. EPL-NCs improved the oral bioavailability as indicated by higher AUC, C max , and lower T max than EPL powder. Acute oral toxicity study showed that EPL-NCs do not pose any toxicity concern to the blood and vital organs. Consequently, NCs prepared by controlled crystallization technique present a promising strategy to improve solubility profile, dissolution velocity and bioavailability of poorly watersoluble drugs.
Fichier principal
Vignette du fichier
Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.pdf (2.88 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03516126 , version 1 (07-01-2022)

Identifiers

Cite

Muhammad Ayub Khan, Muhammad Mohsin Ansari, Sadia Tabassam Arif, Abida Raza, Ho-Ik Choi, et al.. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability. Drug Delivery, 2021, 28, pp.2510 - 2524. ⟨10.1080/10717544.2021.2008051⟩. ⟨hal-03516126⟩
21 View
23 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More